Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Medoxomil + Chlorthalidone in Hypertensive Subjects With Moderate Renal Impairment
NCT01309828Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of azilsartan medoxomil in hypertension (HTN), sponsored by Takeda. Started Mar 2011; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01309828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309828.